Quantifying the effect of cardiorenal syndrome on mortality after left ventricular assist device implant
- 10 October 2013
- journal article
- Published by Elsevier in The Journal of Heart and Lung Transplantation
- Vol. 32 (12), 1205-1213
- https://doi.org/10.1016/j.healun.2013.09.001
Abstract
No abstract availableKeywords
This publication has 38 references indexed in Scilit:
- Fifth INTERMACS annual report: Risk factor analysis from more than 6,000 mechanical circulatory support patientsThe Journal of Heart and Lung Transplantation, 2013
- Impact of Renal Function Before Mechanical Circulatory Support on Posttransplant Renal OutcomesThe Annals of Thoracic Surgery, 2011
- Results of HeartMate II left ventricular assist device implantation on renal function in patients requiring post-implant renal replacement therapyThe Journal of Heart and Lung Transplantation, 2011
- Characteristics of Patients With Improvement or Worsening in Renal Function During Treatment of Acute Decompensated Heart FailureThe American Journal of Cardiology, 2010
- Renal Function, Health Outcomes, and Resource Utilization in Acute Heart FailureCirculation: Heart Failure, 2010
- Renal and Hepatic Function Improve in Advanced Heart Failure Patients During Continuous-Flow Support With the HeartMate II Left Ventricular Assist DeviceCirculation, 2009
- Association of chronic kidney disease with outcomes in chronic heart failure: a propensity-matched studyNephrology Dialysis Transplantation, 2008
- Renal Function as a Predictor of Outcome in a Broad Spectrum of Patients With Heart FailureCirculation, 2006
- Renal Function, Digoxin Therapy, and Heart Failure OutcomesJournal of the American Society of Nephrology, 2004
- Prediction of Creatinine Clearance from Serum CreatinineNephron, 1976